Stromal-induced epithelial-mesenchymal transition induces targetable drug resistance in acute lymphoblastic leukemia is a research paper published in Cell Reports (2023). On theSindex it has a DataRank of 0. It has been cited 33 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph â no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full â never from an abstract alone.
National Cancer Institute
Grant: P30 CA021765
National Cancer Institute
Grant: U10 CA180820
National Cancer Institute
Grant: UG1 CA189859
National Cancer Institute
Grant: R35 CA197695
National Cancer Institute
Grant: UG1 CA232760
NCI NIH HHS
Grant: U24 CA196172
National Institutes of Health
Grant: 5UG1CA189859-03
Minority-Based Community Oncology Research Program
National Institutes of Health
Grant: 5R35CA197695-05
Translating genomic discoveries to improved outcomes for high risk acute leukemia
National Institutes of Health
Grant: 3U10CA180820-02S3
ECOG-ACRIN Operations Center
National Institutes of Health
Grant: 3P30CA021765-41S2
Cancer Center Support Grant (CCSG)
National Institutes of Health
Grant: 3UG1CA232760-06S1
NCI, National Clinical Trials Network Lead Academic Participating Site (LAPS) UG1 (funded extension)
Alex's Lemonade Stand Foundation for Childhood Cancer
National Institutes of Health
St. Jude Children's Research Hospital
FWCI
3.85
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals